Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease
Author:
Affiliation:
1. Department of Pathology; Johns Hopkins University; Baltimore Maryland
Funder
Grifols S.A.
Publisher
Wiley
Subject
Hematology,Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.14212/fullpdf
Reference121 articles.
1. Population based surveillance in sickle cell disease: methods, findings and implications from the California Registry and Surveillance System in hemoglobinopathies project (RuSH);Paulukonis;Pediatr Blood Cancer,2014
2. The influence of clinical and biological factors on transfusion-associated non-ABO antigen alloimmunization: responders, hyper-responders, and non-responders;Gehrie;Transfus Med Hemother,2014
3. Experience with donors matched for minor blood-group antigens in patients with sickle-cell-anemia who are receiving chronic transfusion therapy;Ambruso;Transfusion,1987
4. Alloantibody formation in sickle cell disease patients receiving multiple transfusions [abstract];Sakhalkar;Blood,2005
5. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center;LaSalle-Williams;Transfusion,2011
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chronic automated red cell exchange therapy for sickle cell disease;Transfusion;2024-07-14
2. Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited;Transfusion;2024-03-18
3. Decreasing alloimmunization‐specific mortality in sickle cell disease in the United States: Cost‐effectiveness of a shared transfusion resource;American Journal of Hematology;2024-01-26
4. Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload;Transfusion;2023-12-08
5. Hemoglobin S target of <50% as compared to 30% in chronic red cell exchange for secondary stroke prevention in sickle cell disease;Journal of Clinical Apheresis;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3